Literature DB >> 15523363

Genetic testing in hereditary melanoma.

Hensin Tsao1, Kristin Niendorf.   

Abstract

Advances in our understanding of molecular genetics bring about unique challenges in our ability to practice molecular medicine. With the availability of commercial testing for various genetic cancer syndromes, including hereditary melanoma, specific issues regarding its use and limitations require attention before full translation of this tool into the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15523363     DOI: 10.1016/j.jaad.2004.04.045

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Clinical applications of melanoma genetics.

Authors:  Michele Gabree; Devanshi Patel; Linda Rodgers
Journal:  Curr Treat Options Oncol       Date:  2014-06

2.  Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists.

Authors:  Suephy C Chen; Michelle L Pennie; Paul Kolm; Erin M Warshaw; Eric L Weisberg; Katherine M Brown; Michael E Ming; William S Weintraub
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

Review 3.  Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanoma.

Authors:  Philip Eliades; Keith T Flaherty; Hensin Tsao
Journal:  Melanoma Manag       Date:  2015-05-18

Review 4.  Current understanding of epigenetics role in melanoma treatment and resistance.

Authors:  Mohsen Karami Fath; Ali Azargoonjahromi; Asma Soofi; Faezeh Almasi; Shahnaz Hosseinzadeh; Saeed Khalili; Kamran Sheikhi; Saeid Ferdousmakan; Soroor Owrangi; Minoovash Fahimi; Hamidreza Zalpoor; Mohsen Nabi Afjadi; Zahra Payandeh; Navid Pourzardosht
Journal:  Cancer Cell Int       Date:  2022-10-12       Impact factor: 6.429

5.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

6.  Racial differences in six major subtypes of melanoma: descriptive epidemiology.

Authors:  Yu Wang; Yinjun Zhao; Shuangge Ma
Journal:  BMC Cancer       Date:  2016-08-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.